Evidence map›Paper›PMID 25231362›Full record

ArticleNeurogenetics2015

Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach.

Magdalena Zimoń, Esra Battaloğlu, Yesim Parman, Sevim Erdem, Jonathan Baets, Els De Vriendt, Derek Atkinson, Leonardo Almeida-Souza, Tine Deconinck, Burcak Ozes and 17 more

Open access · greenAbstract read
In one paragraph

Article in Neurogenetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Impaired Mitochondrial Mobility in Charcot-Marie-Tooth Disease.Frontiers in cell and developmental biology · 2021
    Article
  10. Article
  11. Article
  12. Investigation of Mutations in Exon 14 ofIranian journal of child neurology · 2020
    Article
  13. NovelBioMed research international · 2019
    Article
  14. Exome sequencing reveals a novelExperimental and therapeutic medicine · 2018
    Article
  15. Article
  16. Axonal neuropathy with neuromyotonia: there is a HINT.Brain : a journal of neurology · 2017
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 14 institutions in 8 countries.

Magdalena ZimońMolecular Neurogenomics Group, VIB Department of Molecular Genetics, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.
Esra Battaloğlu
Yesim Parman
Sevim Erdem
Jonathan Baets
Els De Vriendt
Derek Atkinson
Leonardo Almeida-Souza
Tine Deconinck
Burcak Ozes
Dirk Goossens
Sebahattin Cirak
Philip Van Damme
Mohammad Shboul
Thomas Voit
Lionel Van Maldergem
Bernard Dan
Mohammed S El-Khateeb
Velina Guergueltcheva
Eduardo Lopez-Laso
Nathalie Goemans
Amira Masri
Stephan Züchner
Vincent Timmerman
Haluk Topaloğlu
Peter De Jonghe
Albena Jordanova
University of Antwerp · BEBoğaziçi University · TRHacettepe University · TRKU Leuven · BEUniversity of Jordan · JOAgency for Science, Technology and Research · SGChildren's National · USHospital Universitario Reina Sofía · ESIstanbul University · TRMedical University of Sofia · BGSorbonne Université · FRUniversité de franche-comté · FRUniversité Libre de Bruxelles · BEUniversity of Miami · US

Funding

trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI SHY, MICHAEL E. · 2009 to 2023
$19.6M
Genomic Studies in Charcot-Marie-Tooth DiseaseR01NS075764 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI SHY, MICHAEL E., ZUCHNER, STEPHAN · 2012 to 2016
$3.0M
The Pathophysiology of CMT2A in Cell and Animal ModelsR01NS052767 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ZUCHNER, STEPHAN · 2006 to 2010
$1.7M
NINDS NIH HHS R01 NS052767NINDS NIH HHS R01 NS075764NINDS NIH HHS R01NS075764NINDS NIH HHS U54 NS065712NINDS NIH HHS U54NS065712
6 · The paper itself

Abstract

Autosomal recessive forms of Charcot-Marie-Tooth disease (ARCMT) are rare but severe disorders of the peripheral nervous system. Their molecular basis is poorly understood due to the extensive genetic and clinical heterogeneity, posing considerable challenges for patients, physicians, and researchers. We report on the genetic findings from a systematic study of a large collection of 174 independent ARCMT families. Initial sequencing of the three most common ARCMT genes (ganglioside-induced differentiation protein 1—GDAP1, SH3 domain and tetratricopeptide repeats-containing protein 2—SH3TC2, histidine-triad nucleotide binding protein 1—HINT1) identified pathogenic mutations in 41 patients. Subsequently, 87 selected nuclear families underwent single nucleotide polymorphism (SNP) genotyping and homozygosity mapping, followed by targeted screening of known ARCMT genes. This strategy provided molecular diagnosis to 22% of the families. Altogether, our unbiased genetic approach identified pathogenic mutations in ten ARCMT genes in a total of 41.3% patients. Apart from a newly described founder mutation in GDAP1, the majority of variants constitute private molecular defects. Since the gene testing was independent of the clinical phenotype of the patients, we identified mutations in patients with unusual or additional clinical features, extending the phenotypic spectrum of the SH3TC2 gene. Our study provides an overview of the ARCMT genetic landscape and proposes guidelines for tackling the genetic heterogeneity of this group of hereditary neuropathies.

Indexed as

MutationCharcot-Marie-Tooth DiseaseChromosome MappingDNA Mutational AnalysisFemaleGenes, RecessiveHomozygoteHumansIntracellular Signaling Peptides and ProteinsMaleNerve Tissue ProteinsPhenotypePolymorphism, Single NucleotideProteinsGDAP proteinHINT1 protein, humanIntracellular Signaling Peptides and ProteinsNerve Tissue ProteinsProteinsSH3TC2 protein, human

Identifiers

PMID25231362
PMCPMC4917005
OpenAlexW2035855619

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.